Director/PDMR Shareholding

Syntopix Group plc
08 January 2007


SYNTOPIX GROUP plc ('the Company')

Notification of Change in Interests of Directors

On 8 January 2007 options ('Options') were granted to directors of the Company
in respect of an aggregate of 85,260 ordinary shares of 10p each in the Company
('Ordinary Shares'). The Options, taken with existing options over Ordinary
Shares, will, if exercised, represent 1.38 per cent. of the then enlarged issued
share capital of the Company. All Options were granted with an exercise price of
176.5p per Ordinary Share (the closing mid-market price on 3 January 2007). No
amounts were paid for the grants themselves.

Dr Rod Adams was granted 56,840 Options, which will vest on 18 January 2008 on
the condition that Dr Adams remains Chairman of the Company at that date.
Following this announcement Dr Adams holds 183,485 Ordinary Shares (3.28% of the
existing issued share capital) and 56,840 options over Ordinary Shares in the
capital of the Company. These Options, taken with existing options over Ordinary
Shares, will, if exercised, represent 0.92 per cent. of the then enlarged issued
share capital of the Company.

Darren Bamforth was granted 14,210 Options, which will vest on 18 January 2008
on the condition that Mr Bamforth continues in the position of Finance Director
into the second year following the flotation of the Company. Following this
announcement Mr Bamforth holds 2,825 Ordinary Shares (0.05% of the existing
issued share capital) and 42,630 options over Ordinary Shares in the capital of
the Company. These Options, taken with existing options over Ordinary Shares,
will, if exercised, represent 0.23 per cent. of the then enlarged issued share
capital of the Company.

Dr Helen Shaw was granted 14,210 Options, which will vest on 18 July 2007.
Following this announcement Dr Shaw holds no Ordinary Shares and 42,630 options
over Ordinary Shares in the capital of the Company. These Options, taken with
existing options over Ordinary Shares, will, if exercised, represent 0.23 per
cent. of the then enlarged issued share capital of the Company.

Enquiries:

Syntopix Group plc

Dr Stephen Jones, Chief Executive Officer (01274 236621)

Mr Darren Bamforth, Finance Director (01274 236621)



                      This information is provided by RNS
            The company news service from the London Stock Exchange